April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Aptevo Therapeutics (APVO) stock forecast for 2026
Updated: May 12, 2025 (04:12)
Sector: HealthcareThe share price of Aptevo Therapeutics Inc. (APVO) now
50/200 Day Moving Average: $1.508 / $6.75
This figure corresponds to the Average Price over the previous 50/200 days. For Aptevo Therapeutics stocks, the 50-day moving average is the resistance level today.
For Aptevo Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Aptevo Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aptevo Therapeutics stock price in 2026. How much will one Aptevo Therapeutics share be worth in 2026? Is it worth taking profit / loss on APVO stock now or waiting? What are analysts' forecasts for Aptevo Therapeutics stock?
We forecast Aptevo Therapeutics stock performance using neural networks based on historical data on APVO stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Aptevo Therapeutics Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Aptevo Therapeutics analysts is $21. Today 200 Day Moving Average is the resistance level (6.75 $). 50 Day Moving Average is the resistance level (1.508 $).
Historical and forecast chart of Aptevo Therapeutics Inc. stock
The chart below shows the historical price of Aptevo Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the APVO stock price can be found in the table below.
Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targets CD123 and CD3 and redirects T-cell cytotoxicity to the tumor; ALG.APV-527, for the treatment of a broad spectrum of cancers over-expressing the 5T4 tumor antigen, including mesothelioma, non-small-cell-lung, head & neck, pancreatic, renal, ovarian, and bladder cancers; and APVO603.
Aptevo Therapeutics (APVO) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | -1 439.75 | -9 760.38 | 6 620.86 | 247.42 % |
| Feb | -5 080.03 | -32 144.90 | 22 443.60 | 243.23 % |
| Mar | -15 172.00 | -90 523.80 | 50 589.60 | 278.94 % |
| Apr | 43 739.40 | -157 694.00 | 332 065.00 | 147.49 % |
| May | 205 676.00 | -1 187 260.00 | 1 097 160.00 | 208.21 % |
| Jun | -388 645.00 | -2 424 130.00 | 1 401 180.00 | 273.01 % |
| Jul | -1 511 670.00 | -6 425 820.00 | 6 951 580.00 | 192.44 % |
| Aug | -146 632.00 | -715 991.00 | 912 640.00 | 178.45 % |
| Sep | 210 872.00 | -531 756.00 | 610 749.00 | 187.07 % |
| Oct | 1 791 340.00 | -7 752 370.00 | 9 717 460.00 | 179.78 % |
| Nov | 497 275.00 | -2 152 060.00 | 3 460 930.00 | 162.18 % |
| Dec | 3 056 800.00 | -16 817 300.00 | 14 926 000.00 | 212.67 % |
Aptevo Therapeutics information and performance
2401 4TH AVE., SUITE 1050, SEATTLE, WA, US
Market capitalization of the Aptevo Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of APVO shares in the company outstanding by the market price of one share.
EBITDA of Aptevo Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Aptevo Therapeutics price target for 2026 by month
Target values for the price of one Aptevo Therapeutics share for Jan 2026.
In Jan, the Negative dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 247.419% volatility is expected.
Pessimistic target level: -9 760.38
Optimistic target level: 6 620.86
Target values for the price of one Aptevo Therapeutics share for Feb 2026.
In Feb, the Negative dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 243.225% volatility is expected.
Pessimistic target level: -32 144.90
Optimistic target level: 22 443.60
Target values for the price of one Aptevo Therapeutics share for Mar 2026.
In Mar, the Negative dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 278.938% volatility is expected.
Pessimistic target level: -90 523.80
Optimistic target level: 50 589.60
Target values for the price of one Aptevo Therapeutics share for Apr 2026.
In Apr, the Positive dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 147.489% volatility is expected.
Pessimistic target level: -157 694.00
Optimistic target level: 332 065.00
Target values for the price of one Aptevo Therapeutics share for May 2026.
In May, the Positive dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 208.212% volatility is expected.
Pessimistic target level: -1 187 260.00
Optimistic target level: 1 097 160.00
Target values for the price of one Aptevo Therapeutics share for Jun 2026.
In Jun, the Negative dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 273.006% volatility is expected.
Pessimistic target level: -2 424 130.00
Optimistic target level: 1 401 180.00
Target values for the price of one Aptevo Therapeutics share for Jul 2026.
In Jul, the Negative dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 192.437% volatility is expected.
Pessimistic target level: -6 425 820.00
Optimistic target level: 6 951 580.00
Target values for the price of one Aptevo Therapeutics share for Aug 2026.
In Aug, the Positive dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 178.453% volatility is expected.
Pessimistic target level: -715 991.00
Optimistic target level: 912 640.00
Target values for the price of one Aptevo Therapeutics share for Sep 2026.
In Sep, the Positive dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 187.066% volatility is expected.
Pessimistic target level: -531 756.00
Optimistic target level: 610 749.00
Target values for the price of one Aptevo Therapeutics share for Oct 2026.
In Oct, the Positive dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 179.778% volatility is expected.
Pessimistic target level: -7 752 370.00
Optimistic target level: 9 717 460.00
Target values for the price of one Aptevo Therapeutics share for Nov 2026.
In Nov, the Negative dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 162.182% volatility is expected.
Pessimistic target level: -2 152 060.00
Optimistic target level: 3 460 930.00
Target values for the price of one Aptevo Therapeutics share for Dec 2026.
In Dec, the Positive dynamics for Aptevo Therapeutics Inc. shares will prevail with possible monthly volatility of 212.671% volatility is expected.
Pessimistic target level: -16 817 300.00
Optimistic target level: 14 926 000.00
Aptevo Therapeutics (APVO) stock dividend
Aptevo Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 03/27/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
